Predictive modeling of co-infection in lupus nephritis using multiple machine learning algorithms.

Journal: Scientific reports
PMID:

Abstract

This study aimed to analyze peripheral blood lymphocyte subsets in lupus nephritis (LN) patients and use machine learning (ML) methods to establish an effective algorithm for predicting co-infection in LN. This study included 111 non-infected LN patients, 72 infected LN patients, and 206 healthy controls (HCs). Patient information, infection characteristics, medication, and laboratory indexes were recorded. Eight ML methods were compared to establish a model through a training group and verify the results in a test group. We trained the ML models, including Logistic Regression, Decision Tree, K-Nearest Neighbors, Support Vector Machine, Multi-Layer Perceptron, Random Forest, Ada boost, Extreme Gradient Boosting (XGB), and further evaluated potential predictors of infection. Infected LN patients had significantly decreased levels of T, B, helper T, suppressor T, and natural killer cells compared to non-infected LN patients and HCs. The number of regulatory T cells (Tregs) in LN patients was significantly lower than in HCs, with infected patients having the lowest Tregs count. Among the ML algorithms, XGB demonstrated the highest accuracy and precision for predicting LN infections. The innate and adaptive immune systems are disrupted in LN patients, and monitoring lymphocyte subsets can help prevent and treat infections. The XGB algorithm was recommended for predicting co-infection in LN.

Authors

  • Jiaqian Zhang
    School of Advanced Technology, Xi'an Jiaotong-Liverpool University, Suzhou 215123, China.
  • Bo Chen
  • Jiu Liu
    Department of Internal Medicine, Linfen People's Hospital, Linfen, 041500, China.
  • Pengfei Chai
    School of Internet of Things, Jiangnan University, Wuxi, 214122, China.
  • Hongjiang Liu
    Department of Rheumatology and Immunology, West China Hospital, Sichuan University, No. 37 Guo Xue Lane, Wuhou District, Chengdu, 610041, Sichuan, China.
  • Yuehong Chen
    State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing 100071, China.
  • Huan Liu
    Department of Chemical and Biochemical Engineering, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, Fujian, China.
  • Geng Yin
    Department of General Practice, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, China.
  • Shengxiao Zhang
    Department of Rheumatology, The Second Hospital of Shanxi Medical University, No. 382 Wu Yi Road, Taiyuan, 030001, Shanxi, China. shengxiao_zhang@163.com.
  • Caihong Wang
    Department of Rheumatology, The Second Hospital of Shanxi Medical University, No. 382 Wu Yi Road, Taiyuan, 030001, Shanxi, China. snwch@sina.com.
  • Qibing Xie
    Department of Rheumatology and Immunology, West China Hospital, Sichuan University, No. 37 Guo Xue Lane, Wuhou District, Chengdu, 610041, Sichuan, China. xieqibing1971@163.com.